Healio: Driver training software program associated with fewer distractions in ADHD youth
Healio highlighted a recent trial published by University of Cincinnati and Cincinnati Children's Hospital Medical Center researchers that found a driver training software program reduced how often adolescent drivers with ADHD took long glances away from the roadway.
Led by Jeffery N. Epstein, PhD, professor in UC's Department of Pediatrics in the College of Medicine, director of the Cincinnati Children's Center for ADHD and a pediatric psychologist, the research was published in the New England Journal of Medicine.
Teenage drivers with ADHD are twice as likely than neurotypical teens to be in an accident, the researchers wrote, noting a struggle for these teens to sustain visual attention while driving.
In the trial, the researchers evaluated the effectiveness of an enhanced version of the Focused Concentration and Attention Learning (FOCAL+) program, a desktop-based software program that features multiple sessions and simulator training "with immediate auditory feedback" designed to reduce long glances away from the road of 2 seconds or longer.
The teen drivers with ADHD randomly assigned to the FOCAL+ program were found to have significantly fewer long glances from the roadway.
Featured photo at top courtesy of Unsplash.
Related Stories
‘Designer drug’ shows early neuroprotective signal in acute ischemic stroke
October 28, 2025
Medscape highlighted new trial results led by the University of Cincinnati's Eva Mistry that found an experimental drug shows promise in protecting injured brain cells for patients with acute ischemic stroke.
UC Board votes to fund design for YMCA renovation
October 28, 2025
At its October 28, 2025 meeting, the University of Cincinnati Board of Trustees approved $5 million in funding to complete all design and pre-construction services required to renovate the interior of a former YMCA building located at 270 Calhoun Street.
Is menstrual fluid ‘the most overlooked opportunity’ in women’s health?
October 27, 2025
The Guardian recently reported that period blood has long been thought of as ‘stinky and useless’, but startups are exploring using the fluid to test for a wide range of health conditions — including endometriosis.